LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the procurement of one package of LORATADINE TABLETS, identified by NSN 6505013770448, at a fixed unit price of $20.01 for a total contract value of $20.01. The award was issued on July 14, 2026, with a single delivery requirement to be completed by July 29, 2026, at Fort Hood, Texas, under FOB destination terms, meaning the contractor bears all freight costs and responsibilities until the goods arrive at the destination. The shipment must be sent via traceable means, with parcel post explicitly prohibited, and must be marked with the Traceable Control Number W80XYJ61820157 to ensure full supply chain visibility. No specific packaging, preservation, or labeling standards beyond traceability are detailed, and no MIL-STD references are cited. Invoicing must comply with DFARS 252.232-7003, requiring electronic submission through a DoD-approved system, likely WAWF or IPP, to the Defense Finance and Accounting Service in Columbus, Ohio, under payment code SL4701 and accounting identifier 97X4930 5CBX 001 2620 S33189. The procurement was executed under NAICS code 424210 as a straightforward fixed-price supply order, with no option quantities or permitted variance, indicating a Lowest Price Technically Acceptable award basis. Contract administration is handled by Lisa Quinn, the Contracting Officer, with Shairy M. Cartagena serving as the local administrative contact. The contractor’s CAGE code is 1UNB0, with associated manufacturer CAGE codes listed for the pharmaceuticals, but no socioeconomic status, small business certifications, or affirmative representations are disclosed in the available documentation. No FAR clauses, special requirements, or evaluation factors beyond the pricing and delivery terms are provided, suggesting minimal complexity in acquisition method and execution.